[{"id":"6c312eab-5d10-4f8e-9392-52b91758fcf3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05576961","created_at":"2022-10-13T17:57:58.568Z","updated_at":"2024-07-02T16:35:22.475Z","phase":"Phase 1/2","brief_title":"Safety and Efficacy of RX-af01 Combined With PD-1 Antibody","source_id_and_acronym":"NCT05576961","lead_sponsor":"Sun Yat-sen University","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Loqtorzi (toripalimab-tpzi) • RX-af01"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 09/15/2022","start_date":" 09/15/2022","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-01-23"}]